In vivo activation of Treg cells with a CD28 superagonist prevents and ameliorates chronic destructive arthritis in mice.
Win, Stephanie J
In vivo activation of Treg cells with a CD28 superagonist prevents and ameliorates chronic destructive arthritis in mice. [electronic resource] - European journal of immunology 05 2016 - 1193-202 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1521-4141
10.1002/eji.201546104 doi
Animals
Antibodies, Monoclonal--administration & dosage
Arthritis, Experimental--prevention & control
Autoimmune Diseases--immunology
CD28 Antigens--agonists
Chronic Disease--prevention & control
Disease Models, Animal
Glucose-6-Phosphate Isomerase--administration & dosage
Inflammation--prevention & control
Joints--immunology
Mice
T-Lymphocytes, Regulatory--immunology
Th1 Cells--immunology
In vivo activation of Treg cells with a CD28 superagonist prevents and ameliorates chronic destructive arthritis in mice. [electronic resource] - European journal of immunology 05 2016 - 1193-202 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1521-4141
10.1002/eji.201546104 doi
Animals
Antibodies, Monoclonal--administration & dosage
Arthritis, Experimental--prevention & control
Autoimmune Diseases--immunology
CD28 Antigens--agonists
Chronic Disease--prevention & control
Disease Models, Animal
Glucose-6-Phosphate Isomerase--administration & dosage
Inflammation--prevention & control
Joints--immunology
Mice
T-Lymphocytes, Regulatory--immunology
Th1 Cells--immunology